Cognition Therapeutics's total assets for Q1 2026 were $36.14M, a decrease of -25.32% from the previous quarter. CGTX total liabilities were $6.23M for the fiscal quarter, a -55.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.